R.PR
REGISTERED-PRINCIPAL REGISTER
01/11/2022
Back to search
Official data from USPTO
IMMUNO8
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
01/11/2022
Trademark type
Word
Nice classes
1, 42
Filing date
07/01/2020
Registration date
01/11/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/11/2022
Last transaction
01/11/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/10/2020
First use in commerce
07/10/2020
Drawing code
4
Owner type
03
Owner location
Cambridge, MA
Examiner
EULIN, INGRID C
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Ultivue, Inc.
Representatives
Monica Riva Talley STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic biomarker reagents for research and laboratory purposes
Class 42
Laboratory research services in the field of biological imaging
Publications
History of USPTO decisions and trademark events.
25 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/04/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/28/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/27/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/27/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/27/2021
GNRT
NON-FINAL ACTION E-MAILED
03/27/2021
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/27/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/10/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/09/2021
EX1G
SOU EXTENSION 1 GRANTED
03/09/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/25/2021
IUAF
USE AMENDMENT FILED
02/09/2021
EXT1
SOU EXTENSION 1 FILED
02/09/2021
EEXT
SOU TEAS EXTENSION RECEIVED
02/09/2021
EISU
TEAS STATEMENT OF USE RECEIVED
02/09/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/15/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/20/2020
PUBO
PUBLISHED FOR OPPOSITION
10/20/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/30/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2020
DOCK
ASSIGNED TO EXAMINER
09/14/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/29/2020
NWAP
NEW APPLICATION ENTERED
07/04/2020
Continuous trademark protection
Get notified about every new filing that threatens IMMUNO8 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.